Press Releases
EC Approves ADCETRIS with AVD, the First New Treatment in Decades for Adults with CD30+ Stage IV Hodgkin Lymphoma
Takeda Pharmaceutical Co. announced that the EC extended the current marketing authorization of ADCETRIS to include treatment of adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma in combination with AVD (Adriamycin, vinblastine and dacarbazine). ...
Press Releases
Lonza Launches New Reliable, Robust and Customizable Pooled Donor Suspension Hepatocytes
Lonza announces the launch of DonorPlex Hepatocytes, a new line of high-quality cryopreserved pooled donor suspension hepatocytes, which are the first of their kind to be produced using Lonza’s novel patented manufacturing process. Researchers within DMPK...
Press Releases
MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease
MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist...
Press Releases
Silgan Dispensing’s Iridya Addresses Unmet Patient Needs in Ophthalmic Drug Delivery Market
Silgan Dispensing, a global leader in the design, development and manufacturing of highly engineered pumps and sprayers in the pharmaceutical, home and beauty markets, will highlight its newest ophthalmic dispensing solution, Iridya™, at this year’s Pharmapack, Europe’s dedicated Pharmaceutical...
Press Releases
Marken To Build New GMP-Compliant Facility In Philadelphia
Marken announced the expansion of its facilities in Philadelphia to include more space for logistics operations as well as a new GMP-compliant storage and distribution center to meet the growing demand for services in the area. ...
Press Releases
Pexidartinib Granted Priority Review by FDA for Treatment of Tenosynovial Giant Cell Tumor
Daiichi Sankyo Company, Limited announced that the U.S. FDA has accepted a New Drug Application (NDA) and granted Priority Review for pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT). Which...
Press Releases
Dotmatics and TetraScience Announce Strategic Partnership and Technology Integration
Dotmatics and TetraScience announced that they have formed a strategic partnership. The partnership is designed to bring R&D labs an improved relationship with their scientific data. Dotmatics is a leading provider of scientific informatics solutions and services; TetraScience is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read